HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Cohort
Saudi Arabia study finds most insulin and anticoagulant errors occur during prescribing
Insulin and Blood Thinners Behind Thousands of Drug Errors
This retrospective observational real-world study analyzed 63,817 medication error reports from Saudi Arabia involving adults (>18 years). T…
Insulin and blood thinners caused most of the 63,817 drug errors reported in Saudi Arabia between 2020 and 2023, with pharmacists catching t…
Frontiers
Apr 19, 2026
Hematology
Observational study identifies PF4-dependent antibodies in ELISA-negative HIT patients via functional testing
Could stopping blood thinners because of a false negative test actually harm you?
This observational research article with an animal component evaluates PF4-dependent platelet-activating antibodies in ELISA-negative patien…
Standard blood tests for a dangerous clotting disorder missed six patients, leading doctors to stop life-saving medicine and causing new clo…
medRxiv
Apr 18, 2026
Cardiology
Cohort
Methylene blue arterial perfusion increases lymph node detection in rectal cancer resection patients
Blue Dye Helps Surgeons Find More Cancer Cells
A retrospective cohort study of 120 patients undergoing radical rectal cancer resection found that methylene blue arterial perfusion with he…
A simple blue dye injection helps surgeons find more cancer cells, leading to better treatment plans for people with rectal cancer.
Frontiers
Apr 16, 2026
Cardiology
RCT
Higher vs lower heparin dosing for elective PCI tested in cluster randomized trial design
Trial will compare two heparin doses for elective heart procedures
A cluster randomized crossover trial design paper outlines a study comparing higher-dose (100 units/kg) versus lower-dose (70 units/kg) unfr…
A new trial will test if a lower dose of heparin works as well as the standard amount for patients having elective heart procedures in Ontar…
Apr 2, 2026